Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog

AI-driven innovation in life sciences: Unlocking the page – 20+ years of digital innovation at Elsevier

Posted on December 2nd, 2021 by

Mark Sheehan is VP Data Science on Elsevier’s Life Science team. His 20 years at the company maps closely with Elsevier’s digital journey over that time. And today, pharmaceutical companies can follow a similar journey – albeit highly accelerated – using Elsevier’s latest AI-driven R&D boosters. Mark has enjoyed many valuable experiences along the way, from the joys of cracking open a newly printed book, to enabling people to speedily crack new synthetic pathways at scale. “Yes, innovation always involves new technology. But it’s equally about human collaboration,” he says.

(more…)

AI-driven innovation in life sciences: Data as data should be

Posted on November 17th, 2021 by

Your AI applications are only as strong as your data. This is why Elsevier strives to make data not only align with FAIR usability principles but also be maximized for trustworthiness and relevance. In this way we can confidently offer the full potential of data science in an easy-to-use manner – from data acquisition and preparation, to AI application and interpretation.

(more…)

AI-driven innovation in Life Sciences: Data Science & AI amplifies your innovative drug R&D capabilities

Posted on November 4th, 2021 by

If you work in Life Sciences & Health, you’re likely aware of what Data Science and AI can bring to the table when it comes to sparking innovation. However, if you are not Big Pharma, it’s the how that slows down most LSH companies and organizations. We believe that Elsevier’s road-tested data and semantic technologies can address the challenges of Life Science data.

(more…)

AI precision medicine accelerates the search for rare disease treatment

Posted on September 20th, 2021 by

AI and precision medicine are both changing drug discovery and development as we know it. Precision medicine that is powered by AI stands to be transformative, especially for the treatment of rare diseases. Elsevier was recently part of a collaboration that sought to demonstrate how AI precision medicine could lead researchers to new treatments for brain tumors faster.

(more…)

  1. 1
  2. 2
  3. 3